These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33440379)
1. Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis. Verzola D; Saio M; Picciotto D; Viazzi F; Russo E; Cipriani L; Carta A; Costigliolo F; Gaggero G; Salvidio G; Esposito P; Garibotto G; Poggi L Am J Nephrol; 2020; 51(12):950-958. PubMed ID: 33440379 [TBL] [Abstract][Full Text] [Related]
2. Focal and segmental glomerulosclerosis: does prognosis vary with the variants? Swarnalatha G; Ram R; Ismal KM; Vali S; Sahay M; Dakshinamurty KV Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):173-81. PubMed ID: 25579744 [TBL] [Abstract][Full Text] [Related]
3. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882 [TBL] [Abstract][Full Text] [Related]
4. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167 [TBL] [Abstract][Full Text] [Related]
5. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study. Weber CL; Rose CL; Magil AB Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972 [TBL] [Abstract][Full Text] [Related]
6. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis? Froes BP; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB Pediatr Nephrol; 2017 Nov; 32(11):2165-2169. PubMed ID: 28799058 [TBL] [Abstract][Full Text] [Related]
9. Urinary miR-196a predicts disease progression in patients with chronic kidney disease. Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065 [TBL] [Abstract][Full Text] [Related]
10. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis. Hao X; Xie J; Ma J; Wang Z; Zhou Q; Yang L; Pan X; Ren H; Chen N Contrib Nephrol; 2013; 181():101-8. PubMed ID: 23689572 [TBL] [Abstract][Full Text] [Related]
11. Differential risk of remission and ESRD in childhood FSGS. Gipson DS; Chin H; Presler TP; Jennette C; Ferris ME; Massengill S; Gibson K; Thomas DB Pediatr Nephrol; 2006 Mar; 21(3):344-9. PubMed ID: 16395603 [TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
13. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients. Danilewicz M; Wagrowska-Danielwicz M Nefrologia; 2009; 29(1):35-41. PubMed ID: 19240770 [TBL] [Abstract][Full Text] [Related]